CCL21 and infarction: Significant differences in the dynamics of the following biomarkers were observed between patients with MI-CAD and MINOCA: the dynamics of the concentrations of CCL21, LIGHT, endocan-1, and sVCAM-1 (p = 0.03) were different after 1 year compared to day 1 during MI-CAD and MINOCA, while the dynamics of CXCL6 and endocan-1 were different after 1 year compared to day 7 of the early post-infarction period (Table 4).